Announced Fri, 17 Jul · 16:52 IST
Jagsonpal completes 85% acquisition of Aequitas Healthcare
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.1%1-day move
₹224.51
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.1-2.4-2.3-1.7+2.4—————
Up moveDown movePending
AI summary
Jagsonpal Pharmaceuticals has completed acquiring an 85% equity stake in Aequitas Healthcare Private Limited, making it an 85% subsidiary. The deal was first announced on June 29, 2026, with updates on July 7 and July 8, 2026. Deal value and financial terms were not disclosed in this filing.
Likely market impact
Grows the company's healthcare business via a majority subsidiary. Deal valuation and earnings impact remain undisclosed in this update.